
Portfolio
reverSASP Therapeutics株式会社
Japan
Active Portfolio
Biotech
Location:
Koto, Tokyo, Japan
Founded: 2022
reverSASP Therapeutics works on the discovery of gene therapies for neurodegenerative diseases, including sporadic amyotrophic lateral sclerosis (ALS).
Other Portfolio Company

RegCell
California, USA, and Suita, Osaka, Japan

Metagen Therapeutics Co., Ltd.
Tsuruoka, Yamagata, Japan

Neusignal Therapeutics
Chuo, Tokyo, Japan

reverSASP
Koto, Tokyo, Japan

Sonire Therapeutics Co., Ltd.
Shinjuku, Tokyo, Japan

Qoly
Shinagawa, Tokyo, Japan

AIRNA
Massachusetts, USA

NovAccel
Tsuchiura, Ibaraki, Japan

Shinobi Therapeutics
California, USA, and Kyoto, Japan

CellFiber
Koto, Tokyo, Japan